New Position Recognizes Her Impact on Growth, Stability and Reputation of Department’s Clinical Enterprise
Bankole A. Johnson, DSc, MD, MBChB, The Dr. Irving J. Taylor Professor and Chair for the Department of Psychiatry, Professor of Pharmacology, Anatomy and Neurobiology, along with UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Jill RachBeisel, MD, Associate Professor of Psychiatry, has been named Vice Chair for Clinical Affairs for the UM SOM Department of Psychiatry, commencing at the start of the next academic year.
Dr. RachBeisel, who also served as Division Head of Community Psychiatry as well as Chief of Clinical Services, brings to the position extensive clinical, teaching, research collaboration and administrative leadership over the past 24 years.
“Dr. RachBeisel has played an integral role in the tremendous growth of our clinical services in Psychiatry and is ideally suited to become our new Vice Chair of Clinical Affairs,” said Professor Johnson, who is also Director of the UM SOM Brain Science Research Consortium Unit.
In her new position, she will oversee the clinical operations of all programs within the Department of Psychiatry, which includes the coordination of seven major clinical Divisions: Adult, Alcohol and Drug Abuse, Child and Adolescent, Community, Consultation-Liaison, Geriatrics, and FPI practices. Among the new initiatives she will manage is the establishment of a Women‘s Mental Health Program, which is collaboration with the Departments of OB/GYN, Family Medicine and Pediatrics as well as with divisions within the Department of Psychiatry.
“As the Vice Chair of Clinical Affairs of the Department of Psychiatry, I see coordinating the mission of the hospital of UMMC, UMMS, and UMB as a major priority,” said Dr. RachBeisel. “I will be focusing on population health initiatives, the new challenges of the global budget, and the increasing demands for mental health and behavioral health services.”
Dr. RachBeisel began her career in the field of acute psychiatric care, emergency psychiatric interventions and quality management in the hospital setting.
During her tenure in Community Psychiatry, she developed a skills based teaching program for individuals with serious mental illness (SMI) living in supervised transitional housing. Her Curriculum, entitled “Academy of Independent Living,” is designed to prepare persons with SMI to live independently.
In addition, she is actively involved in understanding the impact of Population Health Management on persons with SMI as well as mental health issues in complex medical/surgical conditions.
“With Dr. RachBeisel’s strong research and clinical background in Adult Psychiatry, Serious and Persistent Mental Illness, substance abuse disorders and women’s mental health, she brings clinical leadership to areas of critical importance to our patients,” said Dean Reece, who is also Vice President for Medical Affairs at the University of Maryland the John Z. and Akiko K. Bowers Distinguished Professor. “We are delighted that she is taking on this new senior role in the Department of Psychiatry.”
Dr. RachBeisel is a graduate of the Pennsylvania State University School of Medicine where she received her medical degree in 1985. She completed her 4 year Psychiatric Residency Program, serving as Chief Resident in her 4th year from the University of Maryland Medical Center Psychiatric Residency Program in 1989.
About the University of Maryland School of Medicine
Celebrating its 210th Anniversary, the University of Maryland School of Medicine was chartered in 1807 and is the first public medical school in the United States and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Maryland’s Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global presence, with research and treatment facilities in more than 35 countries around the world. medschool.umaryland.edu/
• Department of Psychiatry